Showing 5 of 5 recruiting trials for “Dedifferentiated liposarcoma”
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
👨⚕️ Elise F Nassif, University of Texas MD Anderson Cancer Center LAO📍 1 site📅 Started Mar 2026View details ↗
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
👨⚕️ Candace L Haddox, Dana-Farber - Harvard Cancer Center LAO📍 16 sites📅 Started Feb 2024View details ↗
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
👨⚕️ Alexander Shoushtari, MD, Memorial Sloan Kettering Cancer Center📍 2 sites📅 Started Nov 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →